Home health tech awards name top tools for safety
The 2024 Product of the Year Awards highlight 12 top home health tech tools for safety, efficiency, and patient outcomes—selected…
Community Aid Links Mothers to Care
Community aid links mothers to care in remote Gambian villages like Mendy Kunda.
Oxford’s Lassa Fever Vaccine Trial Begins in Ghana
Oxford's Lassa fever vaccine trial begins in Ghana, evaluating safety and immune response in 51 healthy adults aged 18-55.
Nigeria confirms first Bundibugyo Ebola case
Nigeria confirms its first Bundibugyo Ebola case in 2024, marking a rare detection after 12 years free of Ebola transmission.
GLP-1 medications alter weight loss environment
GLP-1 medications alter weight loss environment by curbing hunger and reducing food intake effectively.
Pfizer submits vitiligo data for oral drug approval
Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.
Instacart and Unite Us partner on food benefits
Instacart and Unite Us partner on food benefits to simplify rollout of food-as-medicine initiatives for providers nationwide with grocery benefits.
FDA clears DreaMed’s CGM-based insulin dosing tool
FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients using multiple…
Doctors Remain Liable for AI Mistakes in Healthcare
AI liability in healthcare raises concerns as doctors may be held responsible for mistakes made by decision-support tools, prompting tighter…
ADARx Raises $535M in IPO for RNA-Targeted Therapies
ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.